Favipiravir in patients hospitalised with COVID-19 (PIONEER trial): a multicentre, open-label, phase 3, randomised controlled trial of early intervention versus standard care

Pallav L. Shah, Dilys Lai, Beatriz Grinsztejn et al.|The Lancet Respiratory Medicine|2022

Cited by 58